Evaluating new contraceptive options using progestogenic androgens
Official title: PROTOCOL FINALIZATION, START-UP, COORDINATION, MONITORING, AND ALL OTHER ASSOCIATED ACTIVITIES FOR CLINICAL TRIALS EVALUATING PROGESTOGENIC ANDROGENS AS CONTRACEPTIVE AGENTS
Funded at Health Decisions, INC. · NIH-11196837 · Data updated 2026-11-12
This study is looking for safe and effective birth control options for both men and women by testing new medications that can help prevent pregnancy, and it's inviting people from different backgrounds to join in and help us learn more about these potential options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Health Decisions, INC. NIH-funded |
| Lab location | 1 site (Morrisville, United States) |
| Project start | September 25, 2024 |
| Project end | December 24, 2025 |
| Funding year | 2024 |
| Award (this year) | $994,099 |
| NIH project number | 75N94019D00004-0-759402400001-1 |
| Project ID | NIH-11196837 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include healthy cis male volunteers interested in contributing to the development of new contraceptive methods.
✕Less likely to help
Patients who are not cis male or those who are not seeking contraceptive options may not benefit from this research.
What this research studies
This research focuses on developing safe and effective contraceptive methods for both men and women by investigating progestogenic androgens. These drugs work by binding to androgen and progesterone receptors, which can disrupt normal reproductive functions, thereby preventing pregnancy. The study involves clinical trials that assess the safety and efficacy of these agents in diverse populations. Participants may be involved in various phases of the trial, contributing to the understanding of these potential contraceptive options.
Why it matters
Potential benefit: If successful, this research could lead to new, effective contraceptive methods that are safe for a wide range of individuals.
How similar studies have gone: Previous studies have shown promising results with similar approaches, indicating the potential for success in this area of research.
Where this research is happening
-
Health Decisions, INC.
Morrisville, United States Active
Researchers
- Principal investigator: Dart, Clint — Health Decisions, INC.
- Study coordinator: Dart, Clint
Related research
Other NIH-funded projects on the same topics.
-
Testing a new gel for male contraception
This study is looking at a new gel that combines Nestorone and Testosterone to see if it can safely help men prevent pregnancy by reducing sperm production, giving them another option for contraception besides condoms and vasectomy.
-
Developing new contraceptive methods for effective pregnancy prevention
This study is exploring new birth control options to help prevent unplanned pregnancies, and it's open to people who want to try out these methods in a safe and controlled setting.
-
Evaluating a new injectable contraceptive for women
This study is testing a new long-lasting birth control shot called levonorgestrel butanoate, which is made for women, especially those who are overweight and may have a higher risk of blood clots, to see how well it works and how it moves through the body, while offering a safer and easier option than taking a pill eve
-
Finalizing the Ovaprene vaginal device trial for contraception
This study is testing a new hormone-free vaginal contraceptive called Ovaprene to see how well it works, and it's looking for about 800 women who can help by participating over the next 13 months.
-
Testing a new gel for male contraception
This study is looking at a new gel that combines Nestorone and Testosterone to see if it can safely and effectively help men prevent pregnancy when used daily, giving couples more options for contraception.
-
Development of a new vaginal ring contraceptive
This study is testing a new vaginal ring that combines hormones to provide a safe and effective birth control option, and we're looking for participants to help us make it the best it can be!
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.